A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours

Anthracyclines are widely used in paediatric oncology, but their use is limited by the risk of cumulative cardiac toxicity. Encapsulating anthracyclines in liposomes may reduce cardiac toxicity and possibly increase drug availability to tumours. A phase I study in paediatric patients was designed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowis, S, Lewis, I, Elsworth, A, Weston, C, Doz, F, Vassal, G, Bellott, R, Robert, J, Pein, F, Ablett, S, Pinkerton, R, Frappaz, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360691/
https://www.ncbi.nlm.nih.gov/pubmed/16880787
http://dx.doi.org/10.1038/sj.bjc.6603288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360691/
https://www.ncbi.nlm.nih.gov/pubmed/16880787
http://dx.doi.org/10.1038/sj.bjc.6603288

Ejemplares similares